Impact of Treating Insomnia Symptoms on Abstinence from Smoking
Vijay Nitturi1, George Kypriotakis, PhD2, Maher Karam-Hage, MD2
University of Houston1, Houston, TX
Department of Behavioral Science, The University of Texas MD Anderson Cancer Center 2, Houston, TX

Background

Table 1. Participant Characteristics

• Quitting smoking prevents cancer in healthy people.1
• Quitting smoking at the time of a cancer diagnosis can increase
survivorship in cancer patients by 30-40%.1
• Insomnia, a disorder in which patients have trouble falling/staying
asleep, can make it harder to quit smoking. 2
• We set out to see if treating insomnia symptoms would help patients
at MD Anderson’s Tobacco Treatment Program quit smoking.

Methods
• Data was extracted from our psychiatry database and the electronic
health records (EHR) of patients who participated in MD Anderson’s
(MDA) Tobacco Treatment Program.
• Initial, middle, and late insomnia were assessed with the brief 4question Jenkins sleep questionnaire, abstinence was based on
subject report, severity of nicotine dependence was based on the
Fagerström test at baseline, and medications prescribed for insomnia
were collected from the EHR.
• We report abstinence by 7-day point prevalence, as a measure of 7
continuous days in the prior week in which cigarettes were not smoked
at 3, 6, and 9 months after starting tobacco cessation treatment.
• The relationship between insomnia score and abstinence was
evaluated after controlling for several possible confounders e.g.
severity of nicotine dependence, anxiety, depression, and the severity
of measured insomnia symptoms.
• Analyses were conducted after propensity score matching was used to
match participants according to each of the characteristics in Table 1.

Not Treated for Insomnia

Treated for Insomnia

% (N)

% (N)

Male

58.41 (1382)

74.10 (123)

White

79.67 (1885)

79.52 (132)

Anxiety

29.90 (690)

42.33 (69)

Panic

13.60 (314)

29.45 (48)

Alcohol

11.35 (262)

8.59 (14)

Major Depression

25.65 (592)

41.10 (67)

Depression

40.60 (937)

57.06 (93)

Age
Center for Epidemiologic
Studies Depression Scale-Total
Fagerström Test for Nicotine
Dependence

Mean (SD)

Mean (SD)

53.81 (10.92)

53.01 (11.77)

18.88 (11.99)

24.62 (12.44)

4.75 (2.27)

4.74 (2.31)

• The differential impact of treating insomnia is likely to be due to
severe insomnia being a marker of other psychiatric disorders;
therefore, treating it might not translate to improved ability to
quit among those patients.
• However, treating individuals with milder or moderate levels of
insomnia may have a positive benefit on their tobacco
abstinence outcomes.
• Therefore, treating insomnia symptoms among cancer
survivors and patients trying to quit smoking can be beneficial
in preventing recurrence of cancer or development of a second
primary cancer.
• Future analyses will aim to control for the co-occurrence of
other psychiatric disorders and their impact on the ability to quit
smoking.
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2532 Smokers who had
insomnia

166 Smokers with insomnia (sleep score ≥
12) who were treated for insomnia

Figure 1. This schematic demonstrates how patients were selected to see if treating
insomnia in smokers who are enrolled in MDA’s Tobacco Treatment program would
have an impact on abstinence rates.

• In propensity score matched analyses, patients treated for
insomnia were more likely to abstain from smoking than patients
not treated for insomnia 9 months after the start of tobacco
cessation treatment. (p = 0.013)
• However, at the 9-month abstinence point, patients treated for
insomnia with sleep scores greater than 14 had lower abstinence
rates than patients not treated for insomnia (Figure 2).
• At 3- and 6-month abstinence points, treatment for insomnia did
not significantly improve abstinence rates compared with the nontreatment group.

Discussion/Conclusions

6141 Smokers treated at MDA Tobacco
Treatment Program

2366 Smokers with insomnia (sleep score
≥ 12) who were not treated for insomnia

Results

Figure 2. These graphs represent abstinence rates at 3 , 6, and 9 months after smokers with insomnia
(sleep score ≥ 12) started tobacco cessation treatment. The abstinence rates are classified by sleep
score at initial psychiatric evaluation.
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